Source:http://linkedlifedata.com/resource/pubmed/id/21241740
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-3-4
|
pubmed:abstractText |
Certain host genetic polymorphisms in human leukocyte antigen (HLA) genes are reported to be associated with response to interferon ? (IFN?) therapy. Two hundred and eighteen IFN? treatment-naïve chronic hepatitis B (CHB) patients were enrolled in the present study. HLA-A, B, C and DQA1, DQB1, DRB1 gene alleles were detected by polymerase chain reaction-sequencing based typing (PCR-SBT) and PCR-sequence specific primer (PCR-SSP), respectively. Frequencies of HLA-DQB1*0303 and DRB1*08 in response group were clearly lower than those in nonresponse group (P=0.019, OR=1.81, 95%CI=1.07-3.15; P=0.031, OR=2.43, 95%CI=1.02-5.98, respectively). Frequencies of haplotype *1101-*4601-*0102 (HLA-A, B, C) and haplotype *0302-*0303-*09 (HLA-DQA1, DQB1, DRB1) were clearly lower than those in nonresponse group (P=0.009, OR=4.84, 95%CI=1.29-19.48; P=0.031, OR=1.94, 95%CI=1.01-3.73, respectively). These results suggest that patients with HLA-DQB1*0303 or DRB1*08 alleles, and haplotype *1101-*4601-*0102 (HLA-A, B, C) or haplotype *0302-*0303-*09 (HLA-DQA1, DQB1, DRB1), might be less responsive to IFN? treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II,
http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1872-9096
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
189-92
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21241740-Female,
pubmed-meshheading:21241740-Gene Frequency,
pubmed-meshheading:21241740-Haplotypes,
pubmed-meshheading:21241740-Hepatitis B, Chronic,
pubmed-meshheading:21241740-Histocompatibility Antigens Class I,
pubmed-meshheading:21241740-Histocompatibility Antigens Class II,
pubmed-meshheading:21241740-Humans,
pubmed-meshheading:21241740-Immunologic Factors,
pubmed-meshheading:21241740-Interferon-alpha,
pubmed-meshheading:21241740-Male,
pubmed-meshheading:21241740-Polymerase Chain Reaction,
pubmed-meshheading:21241740-Polymorphism, Genetic,
pubmed-meshheading:21241740-Sequence Analysis, DNA,
pubmed-meshheading:21241740-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Human leukocyte antigen class I and class II genes polymorphisms might be associated with interferon ? therapy efficiency of chronic hepatitis B.
|
pubmed:affiliation |
National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|